In this interview about his state-of-the-art lecture at EAU21, Dr. Duran shows us what we can achieve with immunotherapy-based management of metastatic clear-cell and variant renal cell carcinoma.
In this interview about his state-of-the-art lecture at EAU21, Dr. Duran shows us what we can achieve with immunotherapy-based management of metastatic clear-cell and variant renal cell carcinoma.